TCTR20170715003
Completed
Phase 4
Dexmedetomidine for prevention of hyperdynamic responses to electroconvulsive therapy
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Patients with psychiatric disease who undergo electroconvulsive therapy
- Sponsor
- Department of Anesthesiology
- Enrollment
- 24
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who need electroconvulsive therapy
- •2\. Age 18\-70 years old
- •3\. ASA PHYSICAL STATUS 1\-3
Exclusion Criteria
- •1\. Pregnancy
- •2\. Hepatic impairment
- •3\. Patients who use beta blocker or narcotic drugs during electroconvulsive therapy
- •4\. Patients who have contraindicated to dexmedetomidine
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Effects of Dexmedetomidine infusion on heamodynamic responses in patients undergoing microlaryngoscopyHealth Condition 1: null- ASA II and IIICTRI/2016/01/006551okmanya Tilak Municipal Medical College and General Hospital60
Completed
Not Applicable
Comparison of incidence of agitation during recovery from anesthesia following administration of dexmedetomidine at induction or at recovery in children undergoing elective surgeryHealth Condition 1: null- Pediatric patients posted for elective surgery under general anesthesiaCTRI/2017/09/009611JIPMER60
Recruiting
Phase 2
octurnal Dexmedetomidine for prevention of delirium in high risk patients admitted to ICU after non-cardiac surgery: a Randomised, Double-Blind, Placebo-Controlled TrialPostoperative deliriumDeliriumDexmedetomidineNocturnal dexmedetomidineTCTR20210217001Faculty of Medicine Siriraj Hospital, Mahidol University114
Completed
Phase 4
A clinical trial intended to study the effect of drug dexmedetomidine in preventing agitation in adults after surgery under general anaesthesiaHealth Condition 1: null- Health patients without any comorbiditiesCTRI/2018/02/012197Tejesh CA100
Recruiting
Not Applicable
Dexmedetomidine as a premedication to reduce emergence agitation and pain in adults after closed reduction of nasal bone fractureInjury, poisoning and certain other consequences of external causesKCT0000585Myongji Hospital116